This open avenues for more research on the application of peptides to target other sepsis inflammatory-microenvironment’s overexpressed components such as selectins, CD44, TREM-1, and protease-activated receptor-1 (PAR-1) [186]. The gene discussed is CD44; the disease is Sepsis.